Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04920136 · ClinicalTrials.gov registry record · NA

Gain of Keratinized Mucosa Around Teeth and Dental Implants Using a Combination of Strip Gingival Graft and Acellular Dermal Matrix

A NA study of Gingival Recession and Lack of Keratinized Attached Peri-implant Mucosa, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04920136: Recruiting NA study of Gingival Recession and Lack of Keratinized Attached Peri-implant Mucosa, sponsored by University of Alabama at Birmingham.

NCT04920136 is a NA study of Gingival Recession and Lack of Keratinized Attached Peri-implant Mucosa that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 20 participants, below the 32-participant average among 10 other Gingival Recession trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04920136, a NA study of Gingival Recession and Lack of Keratinized Attached Peri-implant Mucosa, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study is to compare the two techniques to achieve change in the tissue quality at areas of lack of Keratinized Tissue (KT) using soft tissue grafting with autogenous graft material (Free Gingival Graft)(FGG) vs Strip gingival graft with acellular dermal matrix (ADM) (SGG+ADM).

Primary Outcome

Compare the change in soft tissue quality (attached or keratinized ) between two used soft tissue grafts by superimposing the before and after intraoral scans and the calculating using a software the difference of soft tissue gain between both scans in (mm)

Interventions

  • PROCEDURE Strip Free gingival graft (SGG) + Acellular Dermal Matrix graft (ADM)
  • PROCEDURE Free Gingival graft

Study Locations (1)

Alabama

  • Unversity of Alabama at Birmingham, School of Dentistry - Birmingham

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-09-17
Est. Completion 2027-06-30
Phase NA
University of Alabama at Birmingham

1,160 total trials

What NCT04920136 shows while recruiting

NCT04920136 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 32-participant average among 10 other Gingival Recession trials with a reported enrollment target (37% lower).

The record links to 3 conditions, with Gingival Recession appearing as the primary indexed condition, and to 2 interventions - of which Strip Free gingival graft (SGG) + Acellular Dermal Matrix graft (ADM) is the first listed.

NCT04920136 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT04920136 about?

NCT04920136 is a clinical study titled "Gain of Keratinized Mucosa Around Teeth and Dental Implants Using a Combination of Strip Gingival Graft and Acellular Dermal Matrix". This study is to compare the two techniques to achieve change in the tissue quality at areas of lack of Keratinized Tissue (KT) using soft tissue grafting with autogenous graft material (Free Gingival Graft)(FGG) vs Strip gingival graft with acellular dermal matrix (ADM) (SGG+ADM).

What is the current status of trial NCT04920136?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-09-17. Estimated completion is 2027-06-30.

What conditions does trial NCT04920136 study?

This clinical trial studies the following conditions: Gingival Recession, Lack of Keratinized Attached Peri-implant Mucosa, Thin Gingiva.

What interventions are being tested in trial NCT04920136?

The interventions under investigation include: Strip Free gingival graft (SGG) + Acellular Dermal Matrix graft (ADM) (PROCEDURE), Free Gingival graft (PROCEDURE).

Who is sponsoring clinical trial NCT04920136?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04920136 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gingival Recession

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04920136's enrollment target sits among peer trials

20 10th of 10 higher than 1 of 10 other Gingival Recession trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Gingival Recession trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04920136, the US trial registry maintained by the National Library of Medicine. NCT04920136 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.